| Nome |
# |
|
Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis., file e27ce426-e359-2581-e053-d805fe0acbaa
|
1.953
|
|
Diabetic ketoacidosis with SGLT2 inhibitors, file e27ce430-bbfb-2581-e053-d805fe0acbaa
|
1.191
|
|
Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis: A Meta-analysis, file e27ce42b-1fc8-2581-e053-d805fe0acbaa
|
1.040
|
|
Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders, file e27ce426-c3a6-2581-e053-d805fe0acbaa
|
1.039
|
|
Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis., file e27ce42a-37ee-2581-e053-d805fe0acbaa
|
873
|
|
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance, file e27ce42b-d6a6-2581-e053-d805fe0acbaa
|
827
|
|
Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial, file e27ce426-e450-2581-e053-d805fe0acbaa
|
725
|
|
A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease., file e27ce426-c67a-2581-e053-d805fe0acbaa
|
635
|
|
Non-alcoholic fatty liver disease from pathogenesis to management: an update., file e27ce426-cd53-2581-e053-d805fe0acbaa
|
601
|
|
Emerging molecular targets for the treatment of nonalcoholic fatty liver disease, file e27ce426-c3a5-2581-e053-d805fe0acbaa
|
532
|
|
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies, file e27ce428-4d72-2581-e053-d805fe0acbaa
|
444
|
|
Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease, file e27ce426-aba5-2581-e053-d805fe0acbaa
|
439
|
|
Magnesium and trace element intake after a lifestyle intervention., file e27ce426-dc20-2581-e053-d805fe0acbaa
|
408
|
|
Body fat and C-reactive protein levels in healthy non-obese men., file e27ce429-d01e-2581-e053-d805fe0acbaa
|
377
|
|
Simple lifestyle recommendations and the outcomes of gestational diabetes. A 2×2 factorial randomized trial, file e27ce426-fa06-2581-e053-d805fe0acbaa
|
364
|
|
Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH, file e27ce426-b08a-2581-e053-d805fe0acbaa
|
363
|
|
Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis, file e27ce426-ae72-2581-e053-d805fe0acbaa
|
349
|
|
Noninvasive assessment of liver disease severity with liver fat score and CK-18 in NAFLD: Prognostic value of liver fat equation goes beyond hepatic fat estimation., file e27ce426-b086-2581-e053-d805fe0acbaa
|
325
|
|
TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD., file e27ce42c-10ef-2581-e053-d805fe0acbaa
|
297
|
|
Plasma Adiponectin Levels in Primary Biliary Cirrhosis: A Novel Perspective for Link Between Hypercholesterolemia and Protection Against Atherosclerosis, file e27ce426-ba94-2581-e053-d805fe0acbaa
|
286
|
|
Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver., file e27ce427-0008-2581-e053-d805fe0acbaa
|
272
|
|
Alteration in lipid metabolism after an oral fat load in subjects with NAFLD., file e27ce426-fc71-2581-e053-d805fe0acbaa
|
267
|
|
Resistant hypertriglyceridemia in a patient with high plasma levels of apolipoprotein CII., file e27ce426-9dad-2581-e053-d805fe0acbaa
|
236
|
|
Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH?, file e27ce426-a837-2581-e053-d805fe0acbaa
|
225
|
|
Influence of APOH protein polymorphism on apoH levels in normal and diabetic subjects., file e27ce426-9ea3-2581-e053-d805fe0acbaa
|
223
|
|
Changes in the gut microbiota composition during pregnancy in patients with gestational diabetes mellitus (GDM), file e27ce42d-3345-2581-e053-d805fe0acbaa
|
219
|
|
Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load, file e27ce428-a78c-2581-e053-d805fe0acbaa
|
213
|
|
Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?, file e27ce426-c67b-2581-e053-d805fe0acbaa
|
211
|
|
Contributors to the obesity and hyperglycemia epidemics. A prospective study in a population-based cohort., file e27ce426-dc98-2581-e053-d805fe0acbaa
|
211
|
|
Is left ventricular hypertrophy a low-level inflammatory state? A population-based cohort study., file e27ce426-dc21-2581-e053-d805fe0acbaa
|
200
|
|
Fatty liver and chronic kidney disease: Novel mechanistic insights and therapeutic opportunities, file e27ce42a-4572-2581-e053-d805fe0acbaa
|
198
|
|
Characterization of the carbohydrate structures of apolipoprotein H through concanavalin A affinity chromatography., file e27ce426-9ea4-2581-e053-d805fe0acbaa
|
197
|
|
Qualitative analysis of the carbohydrate composition of apolipoprotein H., file e27ce426-9ea5-2581-e053-d805fe0acbaa
|
197
|
|
Characterization and representative structures of N-oligosaccharides bound to apolipoprotein H., file e27ce426-9db2-2581-e053-d805fe0acbaa
|
189
|
|
Increased liver expression of inflammatory mediators is associated with hepatic insulin resistance in lean, non-diabetic patients with chronic hepatitis C., file e27ce426-d4ef-2581-e053-d805fe0acbaa
|
189
|
|
In vivo oxidizability of LDL in type 2 diabetic patients in good and poor glycemic control, file e27ce426-bb3b-2581-e053-d805fe0acbaa
|
183
|
|
Dietary habits and their relations to insulin sensitivity in non-alcoholic steatohepatitis., file e27ce426-d484-2581-e053-d805fe0acbaa
|
181
|
|
LIVER DAMAGE CAN BE ASSOCIATED WITH DEREGULATION OF THE DE NOVO LIPOGENESIS PATHWAY IN SUBJECTS WITH NON ALCOHOLIC FATTY LIVER DISEASE, file e27ce428-ae68-2581-e053-d805fe0acbaa
|
181
|
|
Increased liver expression of inflammatory mediators is associated with hepatic insulin resistance in lean, non-diabetic CHC patients., file e27ce426-d4ee-2581-e053-d805fe0acbaa
|
180
|
|
Metabolic significance of hepatic steatosis in non alcoholic fatty liver disease and HCV chronic hepatitis, file e27ce426-d485-2581-e053-d805fe0acbaa
|
179
|
|
Is adiponectin a potential protective factor against atherosclerosis in primary biliary cirrhosis (PBC)?, file e27ce426-d4f0-2581-e053-d805fe0acbaa
|
177
|
|
Loxin polymorphism is associated with increased resistin levels and with oxidative status., file e27ce426-dc99-2581-e053-d805fe0acbaa
|
176
|
|
Increased LDL-cholesterol susceptibility to oxidation contributes to oxidative damage in non alcoholic steatohepadtis (NASH)., file e27ce426-d483-2581-e053-d805fe0acbaa
|
173
|
|
Increased hepatic glucose production and insulin resistance in subjects with non-alcoholic fatty liver disease is associated to increased plasma concentrations of glucogenic amino acids, file e27ce42b-0734-2581-e053-d805fe0acbaa
|
171
|
|
Contribution of visceral fat and hepatic fat to metabolic derangements and liver damage in NAFLD patients., file e27ce426-e4b1-2581-e053-d805fe0acbaa
|
169
|
|
Dietary interventions modify the gut microbiota during pregnancy in patients with gestational
diabetes mellitus (GDM), file e27ce42d-6f32-2581-e053-d805fe0acbaa
|
165
|
|
Contribution of visceral fat and hepatic fat to metabolic derangements and liver damage in NAFLD patients., file e27ce426-e6df-2581-e053-d805fe0acbaa
|
161
|
|
Predictive role of the Mediterranean diet on mortality in individuals at low cardiovascular risk: A 12-year follow-up population-based cohort study, file e27ce428-ae4f-2581-e053-d805fe0acbaa
|
152
|
|
Impact of sirtuin-1 expression on H3K56 acetylation and oxidative stress: a double-blind randomized controlled trial with resveratrol supplementation, file e27ce42c-9ab9-2581-e053-d805fe0acbaa
|
144
|
|
Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis., file e27ce426-f22c-2581-e053-d805fe0acbaa
|
143
|
|
The binding of apolipoprotein H (beta2-Glycoprotein I) to lipoproteins., file e27ce426-9daf-2581-e053-d805fe0acbaa
|
139
|
|
Incidence of diabetes mellitus, cardiovascular outcomes and mortality after a 12-month lifestyle intervention: A 9-year follow-up, file e27ce42d-686c-2581-e053-d805fe0acbaa
|
136
|
|
Dietary flavonoid intake and cardiovascular risk: a population-based cohort study, file e27ce427-8f18-2581-e053-d805fe0acbaa
|
130
|
|
The microbiota composition of the offspring of patients with gestational diabetes mellitus (GDM), file e27ce42e-f018-2581-e053-d805fe0acbaa
|
130
|
|
Transcription factor 7-like 2 (TCF7L2) polymorphism and hyperglycemia in an adult Italian population-based cohort., file e27ce426-c679-2581-e053-d805fe0acbaa
|
129
|
|
Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis, file e27ce42c-da69-2581-e053-d805fe0acbaa
|
127
|
|
Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials, file e27ce42d-f428-2581-e053-d805fe0acbaa
|
116
|
|
Phytosterol-Enriched Yogurt Increases LDL Affinity and Reduces CD36 Expression in Polygenic Hypercholesterolemia, file e27ce426-b08c-2581-e053-d805fe0acbaa
|
103
|
|
Lipid modifiers and NASH: statins, ezetimibe, fibrates and other agents, file e27ce427-9016-2581-e053-d805fe0acbaa
|
103
|
|
TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD., file e27ce42b-f25c-2581-e053-d805fe0acbaa
|
100
|
|
Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial, file e27ce42d-6194-2581-e053-d805fe0acbaa
|
94
|
|
Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution, file e27ce42d-1df7-2581-e053-d805fe0acbaa
|
88
|
|
Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease, file e27ce427-74e4-2581-e053-d805fe0acbaa
|
87
|
|
A high dietary saturated fat is associated with insulin resistance in non-alcoholic steatohepatitis., file e27ce426-ea56-2581-e053-d805fe0acbaa
|
71
|
|
Probiotics, prebiotics, energy balance and obesity: mechanistic insights and therapeutic implications., file e27ce426-ec51-2581-e053-d805fe0acbaa
|
69
|
|
New Pharmacologic Agents That Target Inflammation and Fibrosis in Nonalcoholic Steatohepatitis-Related Kidney Disease, file e27ce42b-e101-2581-e053-d805fe0acbaa
|
66
|
|
Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation, file e27ce42e-2320-2581-e053-d805fe0acbaa
|
66
|
|
Lack of relationship between the P1A1/P1A2 polymorphism of platelet glycoprotein IIIa and premature myocardial infarction., file e27ce426-9db1-2581-e053-d805fe0acbaa
|
59
|
|
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease, file e27ce434-2c8c-2581-e053-d805fe0acbaa
|
55
|
|
Sterol Regulatory Element-Binding Factor 2 (SREBF-2) Predicts 7-Year NAFLD Incidence and Severity of Liver Disease and Lipoprotein and Glucose Dysmetabolism., file e27ce426-e6b4-2581-e053-d805fe0acbaa
|
50
|
|
SREBF-1C polymorphism affects postprandial lipid metabolism in NAFLD subjects., file e27ce426-fe01-2581-e053-d805fe0acbaa
|
50
|
|
INCIDENCE AND SEVERITY OF NONALCOHOLIC FATTY LIVER DISEASE ASSOCIATED WITH IMPAIRED LIPID AND GLUCOSE METABOLISM ARE PREDICTED BY SREBF POLYMORPHISM., file e27ce426-e249-2581-e053-d805fe0acbaa
|
49
|
|
Plasma Selenoprotein P levels are related to adipose tissue insulin resistance, composition of free fatty acids and liver fibrosis in non-diabetic patients with Non Alcoholic Fatty Liver Disease, file e27ce42c-40be-2581-e053-d805fe0acbaa
|
49
|
|
Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C, file e27ce426-b089-2581-e053-d805fe0acbaa
|
47
|
|
Apolipoprotein H is not affected by in vitro glycosylation., file e27ce426-9db0-2581-e053-d805fe0acbaa
|
44
|
|
Adiponectin gene polymorphism modulate acute adiponectin response to dietary fat: possible pathogenetic role in NASH, file e27ce426-a80f-2581-e053-d805fe0acbaa
|
44
|
|
The rs553668 polymorphism of ADRA2A gene predicts the worsening of fasting glucose values in a cohort of subjects without diabetes. A population-based study, file e27ce42a-0f81-2581-e053-d805fe0acbaa
|
38
|
|
LECTIN-LIKE OXIDIZED LDL RECEPTOR-1 (LOX-1) POLYMORPHISM IS INDEPENDENTLY ASSOCIATED WITH LIVER HISTOLOGY IN NASH., file e27ce426-ee73-2581-e053-d805fe0acbaa
|
35
|
|
Rs12778366 single nucleotide polymorphism of Sirtuin 1 (SIRT1) and response to resveratrol supplementation in patients with type 2 diabetes mellitus., file e27ce42d-f901-2581-e053-d805fe0acbaa
|
35
|
|
Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial, file e27ce42a-b7b4-2581-e053-d805fe0acbaa
|
34
|
|
La condizione di normopeso, sovrappeso e obeso., file e27ce426-d4f2-2581-e053-d805fe0acbaa
|
30
|
|
Cholesterol-lowering therapy for the treatment of nonalcoholic fatty liver disease: an update., file e27ce426-dbf8-2581-e053-d805fe0acbaa
|
25
|
|
Prevalence of helicobacter pylori cag-a positive strains infection in non-alcoholic steatohepatitis., file e27ce426-ea57-2581-e053-d805fe0acbaa
|
25
|
|
TM6SF2 may drive postprandial cholesterol toxicity away from the vessel walls to the liver in NAFLD, file e27ce428-4784-2581-e053-d805fe0acbaa
|
25
|
|
Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials, file e27ce42e-0d5b-2581-e053-d805fe0acbaa
|
25
|
|
Gut Microbiota as a Modulator of Cardiometabolic Risk: Mechanisms and Therapeutic Implications, file e27ce426-f2c3-2581-e053-d805fe0acbaa
|
23
|
|
Body fat is the main predictor of fibrinogen levels in healthy non-obese men, file e27ce429-c86f-2581-e053-d805fe0acbaa
|
17
|
|
PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in NAFLD., file e27ce427-5759-2581-e053-d805fe0acbaa
|
14
|
|
Trials of obeticholic acid for non-alcoholic steatohepatitis, file e27ce427-537b-2581-e053-d805fe0acbaa
|
12
|
|
Postprandial cholesterol metabolism: a clue to the impact of TM6SF2 rs58542926 variant on liver and cardiovascular disease in NAFLD?, file e27ce42a-208b-2581-e053-d805fe0acbaa
|
12
|
|
Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression, file e27ce431-0881-2581-e053-d805fe0acbaa
|
9
|
|
Plasma lipid abnormalities in atherothrombotic and lacunar infarction., file e27ce426-eaff-2581-e053-d805fe0acbaa
|
8
|
|
Incidence of diabetes mellitus, cardiovascular outcomes and mortality after a 12-month lifestyle intervention: A 9-year follow-up, file e27ce42d-3fb5-2581-e053-d805fe0acbaa
|
6
|
|
Pioglitazone for advanced fibrosis in NASH: New evidence, new challenges, file e27ce42b-4a8e-2581-e053-d805fe0acbaa
|
5
|
|
The rs553668 polymorphism of ADRA2A gene predicts the worsening of fasting glucose values in a cohort of subjects without diabetes. A population-based study, file e27ce427-fa91-2581-e053-d805fe0acbaa
|
4
|
|
Microvascular angina (cardiological syndrome X) per se is not associated with hyperinsulinaemia or insulin resistance, file e27ce42f-5927-2581-e053-d805fe0acbaa
|
4
|
|
Advanced glycation end products and chronic inflammation in adult survivors of childhood leukemia treated with hematopoietic stem cell transplantation, file e27ce42f-7a2e-2581-e053-d805fe0acbaa
|
4
|
|
Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances, file b4ac4dca-98b3-4d2e-87d5-e1b683972279
|
3
|
|
Nonalcoholic steatohepatitis versus steatosis: Adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism, file e27ce426-cefb-2581-e053-d805fe0acbaa
|
3
|
|
PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in NAFLD., file e27ce427-4d49-2581-e053-d805fe0acbaa
|
3
|
| Totale |
21.450 |